Compounds > amphetamine

amphetamine and xanomeline

amphetamine has been researched along with xanomeline in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bickerdike, MJ; Bright, JL; Harrington, NR; Hesselink, MB; Kennett, GA; Lightowler, S; Mirza, NR; Sheardown, MJ; Stanhope, KJ; Syed, R; Upton, RL; Wadsworth, G; Weiss, SM; Wyatt, A1
Andersen, MB; Bymaster, F; Fink-Jensen, A; Gerlach, J; Lundbaek, JA; Peacock, L; Werge, T1
Carter, HJ; Dawson, LA; Gartlon, JE; Watson, JM; Woolley, ML1
Barak, S; Weiner, I1
Dencker, D; Fink-Jensen, A; Jeon, J; Mørk, A; Sager, TN; Thomsen, M; Weikop, P; Wess, J; Woldbye, DP; Wörtwein, G1

Other Studies

5 other study(ies) available for amphetamine and xanomeline

ArticleYear
The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 299, Issue:2

    Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Psychological; Conflict, Psychological; Dopamine; Emotions; Hyperkinesis; Male; Muscarinic Agonists; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Thiadiazoles

2001
The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:6

    Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Cebus; Male; Muscarinic Agonists; Psychotic Disorders; Pyridines; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Receptors, Muscarinic; Thiadiazoles

2003
Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.
    European journal of pharmacology, 2009, Jan-28, Volume: 603, Issue:1-3

    Topics: Amphetamine; Animals; Hyperkinesis; Mice; Mice, Knockout; Muscarinic Agonists; Pyridines; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Substrate Specificity; Thiadiazoles

2009
The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.
    The international journal of neuropsychopharmacology, 2011, Volume: 14, Issue:9

    Topics: Amphetamine; Animals; Antimanic Agents; Behavior, Animal; Cognition Disorders; Dizocilpine Maleate; Dose-Response Relationship, Drug; Kinetics; Male; Molecular Targeted Therapy; Muscarinic Agonists; Neural Inhibition; Neurotransmitter Agents; Pyridines; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Scopolamine; Tachyphylaxis; Thiadiazoles

2011
Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Apr-20, Volume: 31, Issue:16

    Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Hyperkinesis; Mice; Mice, Knockout; Motor Activity; Muscarinic Agonists; Neurons; Pyridines; Receptor, Muscarinic M4; Thiadiazoles

2011